Panitumumab Market
Panitumumab Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Panitumumab Market Size and Growth
The Panitumumab market is witnessing robust growth due to increasing cancer prevalence and advancements in targeted therapies. As of 2023, the global market size for Panitumumab is estimated to reach approximately $1.5 billion. Key trends include rising adoption in colorectal cancer treatment and expanding research initiatives to enhance effectiveness and accessibility.
Companies Covered
(Covid 19 Impact Covered)
The Panitumumab market is competitive, featuring Amgen as a key player. Amgen leverages Panitumumab for targeted cancer therapy, enhancing treatment options and driving market growth. Other companies contribute through innovation and strategic partnerships. Notable sales revenues:
- Amgen: $26 billion
- Other competitors: data varies, typically in billions.
Request Sample Report
Market Segmentation
By Application
Hospital
Drug store
Request Sample Report
By Product
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials
Market Growth
Request Sample Report
$ 6.43 Billion
